Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: July 31, 2023
Reporting Period: Quarter ended June 30, 2023
This filing serves as a notification that the company issued a press release on July 31, 2023, announcing its earnings results for the second quarter of 2023. The detailed financial statements and data are incorporated by reference as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1) and are not explicitly stated in this document.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms the issuance of the earnings announcement.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release containing management commentary and unaudited condensed consolidated financial statements but does not reproduce the content of that commentary.
Risks and Contingencies: No specific risks or contingencies are detailed in this text.
Unusual Items: No unusual items are described in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 31, 2023) for actual revenue, net income, and cash flow figures.
- Verify the unaudited condensed consolidated financial statements included in the press release.
- Check for any forward-looking statements or guidance updates provided in the referenced press release.
- Confirm the trading symbol (KIDS) and exchange (Nasdaq Global Market) for current market data.